The most notable pathway was the negative regulation of interleukin 17 (IL17) production (GO:0038085), where seven genes involved in T-cell and immunocyte activation through interferon gamma harbored mutations in 12% of EA patients, but none in Asian American patients (p-value=0.009) (Figure 2B). This evidence concerns the gene IL17A and Esophageal atresia.